Theseus Pharmaceuticals, Inc. THRX
Set alert
4.07 0.00 0.00%
As of Feb 13, 3:59 PM ET
4.06 Day range 4.07
52-week range unavailable
- Open
- 4.06
- Prev close
- 4.07
- Mkt cap
- 181.50M
- Vol
- 677.69K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.06
- High
- 4.07
- Forward P/E
- -3.79
- Beta
- 3.98
- Short ratio
- 0.82
- Inst. own
- 84.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 14, 2024
- 50-d avg
- 4.02
- 200-d avg
- 4.47
- 1y target
- 5.25
5Y chart
Events in this range
- Nov 3, 2022Earnings: —; estimate -0.34; surprise —%
- Mar 9, 2023Earnings: —; estimate -0.44; surprise —%
- May 11, 2023Earnings: —; estimate -0.42; surprise —%
- May 25, 2023Rating: Needham · Buy → Buy
- May 25, 2023Rating: HC Wainwright & Co. · Buy → Buy
- Jul 13, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
- Jul 13, 2023Rating: Wedbush · Outperform → Outperform
- Jul 13, 2023Downgrade: Needham · Buy → Hold
- Jul 13, 2023Rating: HC Wainwright & Co. · Buy → Buy
- Aug 10, 2023Earnings: —; estimate -0.34; surprise —%
- Nov 17, 2023Earnings: —; estimate -0.35; surprise —%
Signals (32)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Jan 18, 2024 | 2 years ago |
| SMA: Bullish | Nov 15, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 8, 2023 | 2 years ago |
| SMA: Bearish | Jul 18, 2023 | 3 years ago |
| SMA: Bearish | Jul 18, 2023 | 3 years ago |
| SMA: Bullish | Jul 11, 2023 | 3 years ago |
| SMA: Bullish | Jul 11, 2023 | 3 years ago |
| SMA: Bearish | Jun 27, 2023 | 3 years ago |
| SMA: Bullish | Jun 6, 2023 | 3 years ago |
| SMA: Bearish | May 30, 2023 | 3 years ago |
| SMA: Bearish | May 23, 2023 | 3 years ago |
| MACD: Sell Signal | May 23, 2023 | 3 years ago |
| MACD: Buy Signal | May 2, 2023 | 3 years ago |
| SMA: Bullish | Apr 11, 2023 | 3 years ago |
| SMA: Bullish | Apr 4, 2023 | 3 years ago |
| SMA: Bearish | Mar 28, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 14, 2023 | 3 years ago |
| SMA: Bearish | Feb 28, 2023 | 3 years ago |
| RSI: Overbought | Jan 17, 2023 | 3 years ago |
| SMA: Bullish | Jan 10, 2023 | 3 years ago |
Newest 20 of 32.
Analyst view
Consensus: hold
Hold
Price target (mean) 5.25 +29.2% upside
Now 4.07
- Target (low)
- 3.50
- Target (mean)
- 5.25
- Target (high)
- 7.00
Ratings (-1m) 3 1 buy · 2 hold · 0 sell
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 3
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.29 | -0.29 – -0.29 | -0.35 | +17.1% | 0 | 0.0% | 1 |
| Next quarter | -0.44 | -0.44 – -0.44 | -0.34 | -29.4% | 0 | 0.0% | 1 |
| Current year | -1.28 | -1.28 – -1.28 | -1.31 | +2.3% | 0 | 0.0% | 1 |
| Next year | -1.07 | -1.07 – -1.07 | -1.28 | +16.4% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 13, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jul 13, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Jul 13, 2023 | Needham | Downgrade | Buy | Hold |
| Jul 13, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 25, 2023 | Needham | Reiterated | Buy | Buy |
| May 25, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2023 | Needham | Reiterated | Buy | Buy |
| May 11, 2023 | Needham | Reiterated | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 15, 2023 | Stifel | Initiated | — | Buy |
| Mar 9, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 9, 2023 | Needham | Reiterated | — | Buy |
| Dec 13, 2022 | Needham | Initiated | — | Buy |
| Jun 29, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 31, 2021 | Jefferies | Initiated | — | Buy |
| Oct 31, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |
| Oct 31, 2021 | Wedbush | Initiated | — | Outperform |
| Oct 31, 2021 | SVB Leerink | Initiated | — | Outperform |